Rochester Medical Corporation develops, manufactures and markets a range of polyvinyl chloride (PVC)-free and latex-free urinary continence and urine drainage care products for the extended care and acute care markets. The Company's extended care products include a range of male external catheters (MECs) for managing male urinary incontinence and a range of intermittent catheters for managing both male and female urinary retention. Along with its silicone male external catheters, it also sells a range of latex male external catheters in the United Kingdom. Its Magic3 is a range of silicone intermittent catheters. Its extended care products also include the FemSoft Insert, a soft, liquid-filled, conformable urethral insert for managing female stress urinary incontinence in adult females. Effective November 14, 2013, CR Bard Inc acquired the entire share capital of Rochester Medical Corp.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Supplies
SectorN/A
WebN/A
Phone+1-507-5339600
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Rochester Medical (NASDAQ:ROCM) Frequently Asked Questions
What is Rochester Medical's stock symbol?
Rochester Medical trades on the NASDAQ under the ticker symbol "ROCM."
Has Rochester Medical been receiving favorable news coverage?
News headlines about ROCM stock have trended negative on Tuesday, according to InfoTrie. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Rochester Medical earned a coverage optimism score of -2.0 on InfoTrie's scale. They also assigned media coverage about the healthcare company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Rochester Medical.
Who are some of Rochester Medical's key competitors?
Some companies that are related to Rochester Medical include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS) and OraSure Technologies (OSUR).
How can I contact Rochester Medical?
Rochester Medical's mailing address is 1 Rochester Medical Dr NW, STEWARTVILLE, MN 55976-1647, United States. The healthcare company can be reached via phone at +1-507-5339600.
MarketBeat Community Rating for Rochester Medical (NASDAQ ROCM)
MarketBeat's community ratings are surveys of what our community members think about Rochester Medical and other stocks. Vote "Outperform" if you believe ROCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ROCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
